(Q31114573)

29 June 2017

Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data (English)

1 reference

29 June 2017

0 references

1 reference

Paul Heath

7

0 references

Katrin Susanne Kohl

1

object named as

Katrin S Kohl

1 reference

29 June 2017

5

Scott Halperin

1 reference

29 June 2017

Wikke Walop

2

1 reference

29 June 2017

Jane Gidudu

3

1 reference

29 June 2017

Leslie Ball

4

1 reference

29 June 2017

Sandra Jo Hammer

6

1 reference

29 June 2017

Frederick Varricchio

8

1 reference

29 June 2017

Edward Rothstein

9

1 reference

29 June 2017

Anne Schuind

10

1 reference

29 June 2017

Renald Hennig

11

1 reference

29 June 2017

Brighton Collaboration Local Reaction Working Group for Swelling at or near Injection Site

12

1 reference

29 June 2017

language of work or name

English

0 references

publication date

11 May 2007

1 reference

29 June 2017

17

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

29 June 2017

25

1 reference

29 June 2017

31

1 reference

29 June 2017

5858-5874

1 reference

Safety and Immunogenicity of a Pentavalent Combination Vaccine (Diphtheria, Tetanus, Acellular Pertussis, Polio and Haemophilus Influenzae Type b Conjugate) When Administered as a Fourth Dose at 15 to 18 Months of Age

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Immunogenicity and reactogenicity associated with an 18-month booster dose of a new diphtheria-tetanus-whole cell pertussis vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Comparative safety of tetanus-diphtheria toxoids booster immunization in students in Grades 6 and 9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Hib-HB Vaccine Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

The development of standardized case definitions and guidelines for adverse events following immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.056

10.1016/J.VACCINE.2007.04.056

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference